Back

Asante Capital Solutions – Q2 2022 Newsletter

  • Written By: Asante Capital

Our latest newsletter talks about one of the most important topics there is today, Energy Transition, where we focus on how it is one of the major investment themes we have been observing over the past few years.

To read the full newsletter, please click here.

Asante Capital congratulates partner Abingworth on the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million

We are delighted to share that Abingworth, a leading international life sciences investment group, part of global investment firm Carlyle (NASDAQ: CG), today announced the final closing of its new Clinical Co-Development Co-Investment Fund at $356 million.

Asante Capital congratulates its partner Norvestor on closing Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion

We are delighted to share that Norvestor, a leading private equity firm in the Nordics, has closed Norvestor IX SCSp (“Norvestor IX”) at its hard cap of €1.5 billion, exceeding its €1.25 billion target, despite a challenging fundraising environment.

Asante is excited to announce the global expansion of our secondaries business

Asante is excited to announce that Director Sam Cantor is relocating to our New York City office, further strengthening the global expansion of our secondaries business.
Back to top
© Asante 2023
Design by Firedog